ProteomeLab™ PF 2D Analysis of Genetically-Characterized Human Glioma Xenografts

Victoria Ioffe¹, Ashken Movsisyan¹, Jiuhong Yu¹, C. David James², and Oliver Bögler¹ 

1. William and Karen Davidson Laboratory, Hermelin Brain Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI
2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Product Information

• ProteomeLab PF 2D

* All trademarks are the property of their respective owners. Where applicable, the PCR process is covered by patents owned by Roche Molecular Systems, Inc., and F. Hoffman-LaRoche, Ltd.

eLabNotebook Sitemap

©1998 - 2006 Beckman Coulter, Inc.